CARL

Carlsmed, Inc.
NasdaqGSUSDEQUITY Healthcare DELAYED
Last price
14.64
▼ 0.66 (4.31%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
15.30
Day high
15.43
Day low
14.56
Volume
116.18K
Market cap
$399.71M
P/E (TTM)
—
52W range
8.50 – 17.23

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+3.90% +2.0%
1M
-6.15% -7.3%
3M
+20.89% +16.4%
6M
+50.31% +32.1%
YTD
+18.54% +4.3%
1Y
+12.88% -3.5%
3Y
— -82.3%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on CARL open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
+5.99M
Net buying
Buy transactions
9
5.99M shares
Sell transactions
2
990 shares
Net transactions
+11
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
12.30M
Total on file
Bought 5.99MSold 990

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Oct 5, 26
BERTOLINI JEFFREY
Chief Operating Officer
SELL 747 $10.75K Direct
Oct 5, 26
BERTOLINI JEFFREY
Chief Operating Officer
CONVERSION 747 $4.42K Direct
Sep 30, 26
BERTOLINI JEFFREY
Chief Operating Officer
SELL 243 $3.40K Direct
Sep 30, 26
BERTOLINI JEFFREY
Chief Operating Officer
CONVERSION 243 $542 Direct
Sep 28, 26
HEPPENSTALL RICHARD
Chief Financial Officer
STOCK 89.29K $0 Direct
Jun 3, 26
SIDOW KEVIN
Director
STOCK 13.70K $0 Direct
Jun 3, 26
O'BOYLE KEVIN C
Director
STOCK 13.70K $0 Direct
Jun 3, 26
YOUNG PHILIP M
Director
STOCK 13.70K $0 Direct
Jun 3, 26
ROOT JONATHAN D
Director
STOCK 13.70K $0 Direct
Mar 3, 26
CORDONNIER MICHAEL
Chief Executive Officer
CONVERSION 391.69K $264.84K Direct
Mar 2, 26
CORDONNIER MICHAEL
Chief Executive Officer
SELL 197.85K $2.63M Direct
Jan 28, 26
GREENSTEIN LEONARD M
Chief Financial Officer
STOCK 44.98K $0 Direct
Jan 28, 26
DURALL WILLIAM SCOTT
Officer
STOCK 44.98K $0 Direct
Jan 28, 26
CASEY NIALL
Officer and Director
STOCK 44.98K $0 Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
B CAPITAL FUND II, L.P.
Beneficial Owner of more than 10% of a Class of Security — Purchase
CASEY NIALL
Officer and Director 982.56K Stock Award(Grant)
CORDONNIER MICHAEL
Chief Executive Officer 1.55M Conversion of Exercise of derivative security
GREENSTEIN LEONARD M
Chief Financial Officer 188.35K Stock Award(Grant)
HEPPENSTALL RICHARD
Chief Financial Officer 89.29K Stock Award(Grant)
MITTENDORFF ROBERT E. II
Director — Purchase
PRESIDIO MANAGEMENT GROUP XII L.L.C.
Beneficial Owner of more than 10% of a Class of Security — Purchase
ROOT JONATHAN D
Director 6.14M Stock Award(Grant)
SIDOW KEVIN
Director 73.26K Stock Award(Grant)
YOUNG PHILIP M
Director 119.93K Stock Award(Grant)

Fundamentals

TTM · reported
Market cap$399.71M
Enterprise value$332.41M
Revenue (TTM)$63.30M
Gross profit$48.50M
EBITDA$-38.26M
Net income$-36.34M
EPS (TTM)$-1.08
Free cash flow$-26.41M
Total cash$89.22M
Total debt$21.92M
Book value / share$3.09
Shares outstanding27.30M
Float15.59M
Short % of float10.55%
Dividend yield0.00%
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E-10.61
PEG ratio—
Price / sales—
Price / book4.73
EV / revenue5.25
EV / EBITDA-8.69
Gross margin76.63%
Operating margin-58.27%
Profit margin-57.42%
Return on equity-66.14%
Return on assets-28.19%
Debt / equity26.02
Current ratio8.84
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 3 years · 5 quarters
Blank means not reported, not zero
Line item202520242023YoY
Total revenue $50.51M$27.16M$13.78M +85.9%
Operating revenue $50.51M$27.16M$13.78M +85.9%
Cost of revenue $12.47M$7.12M$3.88M +75.2%
Gross profit $38.04M$20.05M$9.90M +89.7%
Research & development $17.02M$14.30M$7.39M +19.0%
Selling, general & admin $51.59M$29.87M$21.10M +72.8%
Total operating expense $68.61M$44.17M$28.49M +55.3%
Operating income -$30.57M-$24.12M-$18.59M -26.7%
Net interest income $1.27M$9.00K-$307.00K +13,988.9%
Pre-tax income -$29.63M-$24.26M-$18.90M -22.2%
Net income -$29.63M-$24.26M-$18.90M -22.2%
Net income to common -$30.22M-$24.85M-$18.90M -21.6%
Basic EPS -2.12-6.11-0.99 +65.3%
Diluted EPS -2.12-6.11-0.99 +65.3%
EBIT -$28.20M-$22.94M-$18.26M -23.0%
EBITDA -$27.92M-$22.79M-$18.12M -22.5%
Basic shares 14.22M4.07M19.17M +249.7%
Diluted shares 14.22M4.07M19.17M +249.7%

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -0.40-0.39 +1.3%
Mar 2026 -0.40-0.26 +33.3%
Dec 2025 -0.43-0.29 +31.5%
Sep 2025 -0.49-0.37 +24.5%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.39 2 $19.16M +46.6%
Next quarter -0.34 2 $22.48M +48.2%
Current year -1.41 2 $76.71M +51.9%
Next year -1.38 2 $108.11M +40.9%

Analyst targets & ownership

Account required
Mean target$19.20
High target$23.00
Low target$17.00
Implied upside31.15%
Analyst count5
ConsensusSTRONG BUY
Strong buy / Buy2 / 3
Hold0
Sell / Strong sell0 / 0
Held by insiders45.04%
Held by institutions40.42%
Institutions holding104
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
14.50
+0.97% from price
SMA 20
14.87
-1.53% from price
SMA 50
14.77
-0.86% from price
SMA 100
13.03
+12.38% from price
SMA 200
12.27
+19.31% from price
EMA 12
14.67
-0.24% from price
EMA 26
14.80
-1.08% from price
EMA 50
14.41
+1.59% from price
RSI (14)
48.4
Neutral
MACD (12,26,9)
-0.12
Hist -0.08
ATR (14)
0.78
5.32% of price
Realised vol 30D
44.3%
Annualised
Bollinger upper
15.95
20, 2σ
Bollinger lower
13.79
20, 2σ
50 / 200 cross
Golden
14.77 vs 12.27
Trend bias
Above 200
+19.31%

Options chain

Account required
Expiry
Spot 14.64
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.08
More volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
44.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-48.0%
Peak to trough
Max drawdown 5Y
-48.0%
Peak to trough
ATR 14
0.78
5.32% of price
Beta (reported)
—
5Y monthly, from filing

Short interest

Semi-monthly exchange report · lags by ~2 weeks
Shares short
1.08M
Prior 1.32M
Change vs prior
-18.0%
Shorts covering
% of float
10.55%
Elevated
% of shares out
3.95%
Against total outstanding
Days to cover
7.8
Crowded exit
Float
15.59M
Freely tradeable shares

Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.

Rating changes

12 on file
DateFirm ActionFromTo
Sep 28, 26 BTIG MAINTAINED Buy Buy
Aug 6, 26 Truist Securities MAINTAINED Buy Buy
Jul 1, 26 Needham INITIATED — Buy
May 6, 26 BTIG MAINTAINED Buy Buy
Apr 15, 26 Truist Securities MAINTAINED Buy Buy
Apr 9, 26 Goldman Sachs MAINTAINED Buy Buy
Dec 15, 25 BTIG MAINTAINED Buy Buy
Nov 7, 25 Truist Securities MAINTAINED Buy Buy
Nov 7, 25 BTIG MAINTAINED Buy Buy
Aug 18, 25 Truist Securities INITIATED — Buy
Aug 18, 25 Goldman Sachs INITIATED — Buy
Aug 18, 25 Piper Sandler INITIATED — Overweight

Dividends & splits

Declared · from the issuer
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.